NCT04354987

Compare the Pharmacokinetics and Safety of CKD-391

Phase I Clinical Trial to Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D090 and D337 in Healthy Adult Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 44 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: Male
• Age: 19 Years – 45 Years
• Healthy volunteers: Accepted

Summary

phase I clinical trial to compare the pharmacokinetics and safety of CKD-391 with co-administration of D090 and D337 in healthy adult volunteers

Conditions

• Hyperlipidemias

Interventions

Type	Name	Description
DRUG	CKD-391 10/10mg	Drug T: CKD-391 10/10mg(Other Name: Test Drug)
DRUG	D090, D337	D090 and D337 co-administration(Other Name: Reference drug)

Timeline

• Start date: 2019-10-30
• Primary completion: 2020-01-09
• Completion: 2020-01-09
• First posted: 2020-04-21
• Last updated: 2020-04-21

Locations

1 site across 1 country: South Korea